By Todd Ellison, MSW, LICSW I often tell people that the experiences I’ve had, however challenging, were necessary to make me who I am today. I am pretty happy with the person I turned out to be, and I think cancer had a lot to do with that. Back in […]
This post originally appeared on the Jimmy Fund Blog. In preparation for his first day of kindergarten, young Michael Sweetman visited his primary care physician. What they anticipated to be a routine checkup left Michael’s parents with more questions than answers. The very next day, the Sweetman’s visited Dana-Farber/Boston Children’s […]
While lymphomas and lymphocytic leukemias are both blood disorders, they are not the same disease. The main difference between lymphomas and lymphocytic leukemias is the location of the cancer cells. In leukemia, they’re found primarily in the bone marrow and blood; in lymphoma, they exist mainly in the lymph system, […]
The past two years have seen a surge of new treatments for blood cancers, such as lymphoma, leukemia and multiple myeloma. Research on the genetic flaws underlying specific cancer types has led to new precision drugs such as ibrutinib and idelalisib and new immunotherapy agents that are improving outcomes in […]
Although treatments for childhood cancer patients are improving, cancer remains the leading cause of death by disease in children. Doctors and researchers are also focused on decreasing the toxicity of these treatments, which can have side effects years after a child finishes treatment. “The war against childhood cancer is hardly […]
This post originally appeared on the Jimmy Fund blog. By Erica Equi “People would say ‘I feel bad for her’…I’m the same person I ever was, but better, stronger,” says 14-year-old Shannon Curley, reflecting on the time she spent in isolation treatment at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. […]
It looked like a scientific dead end – a clinical trial that found no benefit to a potential drug for a form of leukemia. But, like police detectives working a cold case, Dana-Farber scientists gathered hundreds of tissue samples that had been collected for the study – most of them […]
Rapid Heme Panel, a new quick-turnaround genetic diagnostic test, at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), offers some patients with aggressive blood cancers faster diagnoses, and treatments. Instead of sending blood samples to different laboratories for tests that return results in two weeks or more, Rapid Heme Panel puts […]
In the treatment of blood cancers and disorders, doctors and researchers are focusing their sights on the immune system and how to bolster its ability to fight off diseases like leukemia, lymphoma and multiple myeloma. “Understanding how you control the immune system is a big theme in treatment for these […]
Thousands of people learn each year – usually after a routine blood test – that they have a condition that may develop into a blood cancer such as leukemia, lymphoma or multiple myeloma. The news is often followed by an equally surprising addendum: the condition won’t be treated until it […]
Hearing the words “you have cancer” can be hard enough, but what is it like to hear them echoed for a loved one? Having two cancer patients in one family calls for extra strength from everyone involved. Karen Perry was undergoing treatment for ovarian cancer when she and her husband […]
Like many family members of cancer patients, Stephen Matarazzo, DMD, wanted a meaningful way to thank the Dana-Farber caregivers who saved his son Michael’s life. What he came up with involved offering his own professional expertise to protect the smiles of others. A dentist based in Quincy, Mass., Matarazzo provides […]
More than 52,000 new cases of adult leukemia are diagnosed in the U.S. each year. Although it is one of the more common childhood cancers, leukemia is found more often in older adults. As September marks Leukemia and Lymphoma Awareness Month, we look at some important facts about adult leukemia: […]
Kate Franklin was 3½-years old in August 2000, when her mother brought her to the Boston Children’s Hospital emergency room because she was bruising easily and couldn’t seem to shake a strep throat. Loren Walensky, MD, PhD, had just started his fellowship in pediatric hematology/oncology in July, and that night […]
When Lisa Robert is interviewed at Fenway Park for the WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance Foundation (Aug 19-20), her mind will no doubt drift back to 1976, when she was a 7-year-old leukemia patient at Dana-Farber and had the thrill of her life. She threw out the […]
Relapse is a word any cancer patient dreads, but for parents of children with cancer, fear of the cancer coming back can be acute. Yet, “a cure is possible for many patients whose cancer returns,” says Barbara Degar, MD. “We approach the second experience with the same rigor we brought […]
Jessica Tierney never thought she’d experience a harder moment than learning she had cancer at age 15 – until her 7-year-old daughter, Emma, was diagnosed with acute lymphocytic leukemia (ALL) last October. Emma is undergoing treatment at Boston Children’s Hospital and Dana-Farber’s Jimmy Fund Clinic, just as Jessica did […]
By Tom Ulrich One of the hot trends in drug discovery could be called drug re-discovery: finding new uses for drugs that have already received FDA approval for a different indication. It’s an approach that allows researchers and clinicians to rapidly test potential treatments for rare or difficult-to-treat conditions. Because […]
The Food and Drug Administration’s recent approval of the drug ibrutinib offers a major new option for patients with chronic lymphocytic leukemia (CLL) who tried at least one prior therapy, physicians say.
If you’ve ever donated blood or platelets, there’s a reasonable chance that your donation went to help a cancer patient. That’s because cancer and certain treatments can damage blood cells, which means some patients may need transfusions of one or more types of blood components:
By Buck Rogers When I woke up from a 40-minute operation to remove a lymph node from my neck, my Ear, Nose & Throat surgeon approached me with another doctor and said, “I’d like you to meet your oncologist.” My life instantly changed; I was diagnosed with chronic lymphocytic leukemia. […]
By Julia Pettengill Our daughter Sophie was diagnosed with leukemia at age 2½, and received two years of care at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. While I felt tremendous joy and relief when she completed treatment, I also found the experience traumatic.
Stem cell transplantation (sometimes called bone marrow transplants) is a treatment for certain forms of cancer, such as leukemia, lymphoma, and multiple myeloma, as well as other diseases. But before a patient can receive a transplant, stem cells must be collected from a donor (an allogeneic donation) or from the […]
By Tim Crowley This Veteran’s Day, Dana-Farber thanks our patients, survivors, families, and friends who have served or are serving in the armed forces, including survivors Stacey Carroll, Ben Groen, and Tim Crowley, who tells his story below. In June 2010, I was diagnosed with acute myeloid leukemia (AML), a […]
Cancer or blood disorder patients may have central lines, which make it easier to receive certain medications (such as chemotherapy) and have blood tests. The major types of central lines include Port-A-Cath, Hickman, and peripherally inserted central catheter (PICC). Patients receiving stem cell transplants sometimes have central lines. If you have a central […]
by Martha Laperle When my son Ryan ran the Boston Marathon this year, I watched him with a special level of pride. Not only had he completed his first-ever marathon in four hours, but he was running, in large part, because of me. Just over a year earlier, at the […]
September is Childhood Cancer Awareness Month. We asked Lisa Diller, MD, chief medical officer at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, to answer these important questions. What signs might lead a child’s pediatrician to suspect cancer? Cancer is very diverse, and diagnosis is further complicated because many signs and symptoms—like fever, […]
By Stephen Sallan, MD Today, three quarters or more of all childhood cancer patients will be cured of their disease, a higher percentage than ever before. And the numbers will only get better as we learn more about the biology of childhood cancers and develop new ways of treating them.
Just as Dana-Farber tailors treatment and support to children and young adults, the Older Adult Leukemia Program ̶ a specialized, clinical service ̶ addresses the other end of the spectrum: adults who are 65 and older, and have blood cancer such as leukemia or other bone marrow disorders.
Quite a few substances used in traditional medicine in China or other countries have received Food and Drug Administration (FDA) approval as cancer drugs… and their numbers are growing. Some examples are: Arsenic trioxide, made from arsenic sulfide ore, has been used therapeutically for more than 2,400 years. Following promising […]
by Naomi Funkhouser April 2011 was an auspicious month for Hilary Hall. The start of spring marked 15 years of her being cancer-free, as well as the anniversary of her bone marrow transplant in April 1996 at age 12 for acute myelogenous leukemia. It also marked the first time Hall […]
By Jane Roper When our five-year-old daughter was diagnosed with leukemia (ALL) last summer, our world was turned upside down. Extended hospital stays, twice weekly clinic visits, the side effects of chemo and the constant possibility of unexpected hospital admissions mean stress and exhaustion for all of us. And looming […]
With Brigham and Women’s Hospital and Boston Children’s Hospital, Dana-Farber has performed thousands of stem cell/bone marrow transplants for adult and pediatric patients with blood cancers and other serious illnesses. What’s the difference between these two terms? As it turns out, the only real distinction is in the method of […]
Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish […]
Alyssa Ywuc was a 23-year-old nursing student when she was diagnosed with leukemia. After seeing first-hand the work of oncology nurses as a patient, she decided to specialize in oncology nursing. We talked with Alyssa about both sides of the cancer experience – her time as a patient and her future […]
Every Sunday, the Cutter family holds a Chemofeast. The door to their home is open to any and all who wish to attend. It’s a day full of food, beverages, and a lot of laughter, and 15-year-old Blake Cutter gets to choose the menu. Then on Monday, his mother, Lois, […]
Maddie Dillon, 17, did not really understand what cancer was when she was diagnosed at age 8. With the help of Dana-Farber’s Jimmy Fund Clinic, she beat her leukemia, but only briefly. Six months later it came back, and she went through more treatment.
By Karen Lee Sobol I recently learned that the word “patient” shares a Latin root with the word “compassion.” Any one of us can become a patient, for a number of reasons. For me, hearing a diagnosis of Waldenström’s macroglobulinemia flipped a switch. I became a patient in a big way.
When Good Morning America host Robin Roberts revealed that she has myelodysplastic syndrome (MDS), she turned a spotlight on a group of blood disorders that affect an estimated 35,000 to 55,000 people in the United States. In patients with MDS, the bone marrow fails to produce normal quantities of blood cells […]
It’s not always easy to recognize that we live in a golden age. Too often we fail to appreciate the amazing things going on around us because we‘re so caught up in day-to-day activities and pressing demands that we presume that the extraordinary is rather ordinary. So it may be […]
When it comes to finding better drugs for cancer, Dana-Farber oncologist Dr. David Frank is not a patient man. While new cancer science promises to bring novel, improved therapies to the bedside, it can take many years — and Frank isn’t willing to wait. “We need to get new treatments […]
In 1958, when scientists linked an aggressive form of leukemia to infection with a particular virus, some researchers took the discovery as evidence that nearly all cancers are caused by viruses. A cover story in Life magazine in 1962 proclaimed, “Cancer may be infectious.” Today, it is estimated that viruses […]
At this year’s American Society of Hematology Annual Meeting, Dana-Farber scientists presented major findings that could one day improve diagnosis and treatment of blood cancers, extend life, or even cure some diseases. Among the highlights: Steven Treon, MD, PhD, and his colleagues identified a gene mutation that underlies the vast […]